Table 2 Adjusted Risk of CV Mortality among β-blocker users in breast cancer
From: Comparing the effects of various β-blockers on cardiovascular mortality in breast cancer patients
Adjusted Model | Reference | HR (95% CI) | P-value |
|---|---|---|---|
Metoprolol | Carvedilol | 0.63 (0.41–0.96) | 0.03 |
Atenolol | 0.74 (0.44–1.22) | 0.24 |